Identifying and sharing kidney care solutions that reduce risk during the pandemic

Identifying and sharing kidney care solutions that reduce risk during the pandemic

KidneyX COVID-19 Kidney Care Challenge names winners

To date, more than 30 million people in the U.S. have tested positive for the coronavirus. The 37 million Americans living with kidney disease are at increased risk of severe illness from COVID-19, and acute kidney injury — sudden loss of kidney function — affects 20-40% of COVID-19 patients admitted to intensive care. Even worse, the pandemic is exacerbating existing health disparities; COVID-19 disproportionately impacts communities that are already more vulnerable to kidney disease and other conditions.

The scale and severity of the pandemic mean patients, caretakers, and healthcare providers can’t wait for solutions. Over the past year, research centers, hospitals, dialysis centers, and other organizations have developed innovative approaches to everything from patient monitoring, patient education, and vaccine distribution to data management, detection, and telehealth. These frontline innovators have proved that effective solutions can come from anyone, anywhere. That’s why the Kidney Innovation Accelerator (KidneyX), a public-private partnership between the U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN), used open innovation to quickly source and recognize solutions — then share them with other communities.

HHS and ASN recently announced 18 winners in Rounds 1 and 2 of the KidneyX COVID-19 Kidney Care Challenge. The $300,000 challenge, designed and produced by Luminary Labs, is recognizing solutions that could reduce the transmission of coronavirus among people with kidney disease and/or reduce the risk of kidney damage among people who contract the virus. KidneyX has published detailed summaries of the winning solutions, including considerations for implementation and adaptation.

Round 1 winners

Round 2 winners